The Effect of Sodium-Glucose Cotransporter-2 Inhibitors on COVID-19 Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study Using the Common Data Model.

Kyoung Ree LimKwang Jin ChunBum Sung Kim Seung-Hwa Lee

Published in: Journal of clinical medicine (2024)

In the diabetic patients who were diagnosed with COVID-19, SGLT2 inhibitors were associated with improved clinical outcomes in terms of MACCEs. SGLT2 inhibitors might be considered for prescription to diabetic patients in the current context of long COVID-19.

Keyphrases

sars cov
coronavirus disease
type diabetes
respiratory syndrome coronavirus
electronic health record
big data
artificial intelligence
data analysis